Literature DB >> 21963353

Mania following addition of hydroxytryptophan to monoamine oxidase inhibitor.

José V Pardo1.   

Abstract

This case report highlights the risk of nutritional supplements and misinformation obtained from the internet particularly for those on monamine oxdiase inhibitors (MAOIs). Despite sophisticated medical knowledge, this patient, who was taking an MOAI and complying with a tyramine-free diet, used a supplement of hydroxytryptophan that along with the MAOI appears to have precipitated mania, despite no personal or familial history of bipolar disorder. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963353      PMCID: PMC3253963          DOI: 10.1016/j.genhosppsych.2011.08.014

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  10 in total

1.  Case of delirium secondary to phenelzine/L-tryptophan combination.

Authors:  G Alvine; D W Black; D Tsuang
Journal:  J Clin Psychiatry       Date:  1990-07       Impact factor: 4.384

2.  Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan.

Authors:  H G Pope; J M Jonas; J I Hudson; M P Kafka
Journal:  Am J Psychiatry       Date:  1985-04       Impact factor: 18.112

3.  Eosinophilia-myalgia syndrome. Results of national surveillance.

Authors:  L A Swygert; E F Maes; L E Sewell; L Miller; H Falk; E M Kilbourne
Journal:  JAMA       Date:  1990-10-03       Impact factor: 56.272

Review 4.  The making of a user friendly MAOI diet.

Authors:  D M Gardner; K I Shulman; S E Walker; S A Tailor
Journal:  J Clin Psychiatry       Date:  1996-03       Impact factor: 4.384

5.  Two cases of hypomania following the addition of L-tryptophan to a monoamine oxidase inhibitor.

Authors:  D C Goff
Journal:  Am J Psychiatry       Date:  1985-12       Impact factor: 18.112

6.  Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats.

Authors:  Takeshi Izumi; Nobuyuki Iwamoto; Yuji Kitaichi; Akiko Kato; Takeshi Inoue; Tsukasa Koyama
Journal:  Eur J Pharmacol       Date:  2006-02-20       Impact factor: 4.432

7.  Characterization of serotonin-toxicity syndrome (toxidrome) elicited by 5-hydroxy-l-tryptophan in clorgyline-pretreated rats.

Authors:  Zhiyuan Ma; Gongliang Zhang; Chris Jenney; Swapna Krishnamoorthy; Rui Tao
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

8.  Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States.

Authors:  Dima M Qato; G Caleb Alexander; Rena M Conti; Michael Johnson; Phil Schumm; Stacy Tessler Lindau
Journal:  JAMA       Date:  2008-12-24       Impact factor: 56.272

9.  MAOIs in the contemporary treatment of depression.

Authors:  M E Thase; M H Trivedi; A J Rush
Journal:  Neuropsychopharmacology       Date:  1995-05       Impact factor: 7.853

10.  The Newcastle chronic depression study: results of a treatment regime.

Authors:  W A Barker; J Scott; D Eccleston
Journal:  Int Clin Psychopharmacol       Date:  1987-07       Impact factor: 1.659

  10 in total
  1 in total

1.  Treatment-emergent hypomania possibly associated with over-the-counter supplements.

Authors:  William Olsufka; Mary-Ann Abraham
Journal:  Ment Health Clin       Date:  2018-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.